Understand the source comparison
Practical implications of the comparison
The productive way to use the Semax comparison is as a modeling boundary, not a prescription. The Semax literature establishes the concentration range at which this chemical family has been studied at all — roughly the 0.1% to 1% window for intranasal solution
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The productive way to use the Semax comparison is as a modeling boundary, not a prescription. The Semax literature establishes the concentration range at which this chemical family has been studied at all — roughly the 0.1% to 1% window for intranasal solutions, and micrograms-to-low-milligrams total daily amounts in human clinical settings. That window is context for laboratory modeling: it tells a researcher what order of magnitude the parent compound was used at, which is genuinely more informative than a random forum number. It does not tell that researcher what Adamax does, whether Adamax shares Semax’s therapeutic window, or that any of these amounts is appropriate for any purpose. The comparison narrows the uncertainty; it does not eliminate it.
- There is also a units subtlety worth flagging for anyone converting between the two. Because Semax has a known molecular weight (about 813.9 g/mol), a stated milligram amount corresponds to a specific molar quantity, and the intranasal solution strengths (0.1% and 1%) map onto the mg/mL anchors used throughout this article. If an Adamax product is a heavier or lighter analog, the same milligram mass contains fewer or more moles of peptide, so two products delivering “the same mcg” are not necessarily delivering the same number of molecules to the target. For a family whose activity is receptor- and transcription-mediated, molecules — not milligrams — are the currency that matters. This is a further reason that “adamax vs semax dosing” cannot be answered as a simple mcg-for-mcg swap without confirming molecular identity, and why the certificate of analysis is not a bureaucratic nicety but the gate to any honest comparison.
- It is also worth stating that even within the Semax literature the dose–response relationship is not cleanly established for cognition in healthy subjects — the human ACTH(4-10) attention work is old, small, and produced inconsistent, sometimes negative results.[12] So the parent compound itself does not offer a crisp “optimal dose,” which makes any claim of a crisp optimal Adamax dose doubly unsupportable.